[June 22, 2016] |
|
Global Cancer Pain Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AngioChem, BCN Peptides, Kineta - Research and Markets
Research and Markets has announced the addition of the "Cancer
Pain - Pipeline Review, H1 2016" drug pipelines to their
offering.
The report provides comprehensive information on the therapeutics under
development for Cancer Pain, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in
therapeutic development for Cancer Pain and features dormant and
discontinued projects.
The report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities and
helps to create effective counter strategies to gain competitive
advantage.
Scope:
-
The report provides a snapshot of the global therapeutic landscape of
Cancer Pain
-
The reportreviews pipeline therapeutics for Cancer Pain by companies
and universities/research institutes based on information derived from
company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report assesses Cancer Pain therapeutics based on drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Cancer Pain
Companies Mentioned:
-
AngioChem Inc.
-
Aphios Corporation
-
AstraZeneca Plc
-
BCN (News - Alert) Peptides, S.A.
-
Benitec Biopharma Limited
-
BioDelivery Sciences International, Inc.
-
ChironWells GmbH
-
Daewoong Pharmaceutical Co., Ltd.
-
Daiichi Sankyo Company, Limited
-
Fujimoto Pharmaceutical Corporation
-
Grunenthal GmbH
-
GW Pharmaceuticals Plc
-
Hisamitsu Pharmaceutical Co., Inc.
-
Immupharma Plc
-
IntelGenx Corp.
-
Kineta, Inc.
-
Kolon Life Science, Inc.
-
Neurocentrx Pharma Ltd.
-
Nippon Kayaku Co., Ltd.
-
Orion Oyj
-
Pain Therapeutics, Inc.
-
Pfizer Inc.
-
Pharmaleads SA
-
Recordati S.p.A.
-
Ribomic Inc.
-
Trillium Therapeutics Inc.
-
Virobay Inc.
-
WEX Pharmaceuticals Inc.
-
Zynerba Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/c2r3ds/cancer_pain
View source version on businesswire.com: http://www.businesswire.com/news/home/20160622006014/en/
[ Back To TMCnet.com's Homepage ]
|